Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight

Linong Ji; Hongwei� Jiang; Yan Bi; Hua Li; Junhang Tian; Dexue Liu; Yuzhu Zhao; Wei Qiu; Chun‐Jui Huang; Lei Chen; Shao Zhong; Jie Han; Yawei Zhang; Qiufang Lian; Ping Yang; Lingchun Lv; Jieyu Gu; Zihan Liu; Huan Deng; Yanqi Wang; Li Li; Lei Pei; Lei Qian

doi:10.1056/nejmoa2411528

Abstract

This is the authors' abstract. We don't add key points for this paper.

In Chinese adults with overweight or obesity, once-weekly mazdutide at a dose of 4 mg or 6 mg for 32 weeks led to clinically relevant reductions in body weight. (Funded by Innovent Biologics; GLORY-1 ClinicalTrials.gov number, NCT05607680.).

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ji et al. (2025) studied this question.

synapsesocial.com/papers/69dc0d870648942b0a9c7d25 https://doi.org/10.1056/nejmoa2411528

View at Publisher

Ask AI

Bookmark

Share

Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight

Abstract

Ask about this paper

Discussion

Cite This Study

Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading